Results 151 to 160 of about 5,559 (204)
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. [PDF]
EuropaceMerino JL +19 more
europepmc +1 more source
Elective percutaneous stellate ganglion block for prediction of the clinical outcome of robotic bilateral cardiac sympathetic denervation in a patient with Andersen-Tawil syndrome: A case report. [PDF]
Eur J AnaesthesiolBiernacka EK +5 more
europepmc +1 more source
Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages. [PDF]
J ArrhythmFaheem MSB +4 more
europepmc +1 more source
New recommendations for rhythm control-What has changed in the 2023 ACC/AHA/ACCP/HRS and 2024 ESC guidelines for atrial fibrillation, and where does dronedarone fit in? [PDF]
Am Heart J PlusNaccarelli GV, Rackley J, Boriani G.
europepmc +1 more source
Electrophoresis, 2006 A robust, inexpensive, and fully validated CE method for the simultaneous determination of the enantiomers of propafenone (PPF), 5-hydroxy-propafenone (5OH-PPF) and N-despropyl-propafenone (NOR-PPF) in serum and in in vitro media is described.
Minoo Afshar, Wolfgang Thormann
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annals of Emergency Medicine, 1994
Propafenone is an infrequently used class IC antiarrhythmic drug. We report our experience with a patient who overdosed with propafenone and developed coma, seizures, bradycardia, hypotension, and conduction delay. The clinical manifestations and management of this patient are discussed in light of the known pharmacology of propafenone and compared ...
W, Kerns, B, English, M, Ford
openaire +2 more sources
Propafenone is an infrequently used class IC antiarrhythmic drug. We report our experience with a patient who overdosed with propafenone and developed coma, seizures, bradycardia, hypotension, and conduction delay. The clinical manifestations and management of this patient are discussed in light of the known pharmacology of propafenone and compared ...
W, Kerns, B, English, M, Ford
openaire +2 more sources
Annals of Emergency Medicine, 1987
Propafenone is a type 1c antiarrhythmic drug that recently has become available for clinical trials within the United States. We present the case of a 2-year-old child who accidentally ingested 1,800 mg (133 mg/kg) of propafenone. The patient subsequently developed cardiac conduction abnormalities and generalized seizures.
T P, McHugh, D G, Perina
openaire +2 more sources
Propafenone is a type 1c antiarrhythmic drug that recently has become available for clinical trials within the United States. We present the case of a 2-year-old child who accidentally ingested 1,800 mg (133 mg/kg) of propafenone. The patient subsequently developed cardiac conduction abnormalities and generalized seizures.
T P, McHugh, D G, Perina
openaire +2 more sources